Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
U.S. Army researchers are calling for the creation of a national emergency network that would coordinate select digital health technologies, including AI, in fighting COVID-19 now and other public health crises later.
The Lancet has issued four corrections to a research paper that found COVID-19 patients who used the drug hydroxychloroquine have a higher risk of death.
Johns Hopkins radiologists have repurposed a deep learning algorithm designed to detect tuberculosis on chest x-rays to, instead, help identify COVID-19.
The European Union has certified AI software for reading mammograms, clearing the way for a South Korea-based AI vendor to sell another of its AI products across the European Economic Area.
Healthcare providers are still asking the Trump administration for help securing personal protective equipment (PPE) as they continue to care for COVID-19 patients.
As part of its $5 million pandemic response, Amazon is placing more than 8,000 of its Echo Dot devices across dozens of senior-living facilities in parts of California and Washington State.
